Seeking Alpha

GenMark Diagnostics EPS in-line, beats on revenues

  • GenMark Diagnostics (GNMK): Q2 EPS of -$0.25 in-line.
  • Revenue of $5.22M beats by $0.17M. Shares +5.4% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: